(E)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-2-(4-(methylsulfonamido)phenyl)acrylamide

ID: ALA5209242

PubChem CID: 163322276

Max Phase: Preclinical

Molecular Formula: C20H15F6N5O3S

Molecular Weight: 519.43

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)Nc1ccc(/C(=C\n2cnc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)n2)C(N)=O)cc1

Standard InChI:  InChI=1S/C20H15F6N5O3S/c1-35(33,34)30-15-4-2-11(3-5-15)16(17(27)32)9-31-10-28-18(29-31)12-6-13(19(21,22)23)8-14(7-12)20(24,25)26/h2-10,30H,1H3,(H2,27,32)/b16-9+

Standard InChI Key:  WULLCOQWAPGBSM-CXUHLZMHSA-N

Molfile:  

 
     RDKit          2D

 35 37  0  0  0  0  0  0  0  0999 V2000
   -3.7948    0.3468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5485    0.0114    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4623    0.8319    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1274   -0.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2136   -0.9585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5463   -1.4434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6326   -2.2639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7926   -1.1079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7063   -0.2875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3737    0.1974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9526    0.0478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7085    1.1674    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7189   -3.0844    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3863   -2.5995    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9652   -2.7490    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7809    0.8549    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4521    1.6555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5147    2.3700    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2771    3.0844    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6896    2.3700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2770    1.6555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2769    0.2265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6894   -0.4879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5144   -0.4879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9270    0.2263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6895    0.9409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5145    0.9409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0395    0.9411    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3748    0.1874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2381   -0.3645    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7678   -0.4171    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7678   -1.2421    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.4836   -0.8288    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1802   -1.9566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9428   -1.2421    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10  4  2  0
  9 11  1  0
  1 12  1  0
  7 13  1  0
  7 14  1  0
  7 15  1  0
 11 16  2  0
 20 19  2  0
 20 18  1  0
 21 17  2  0
 21 20  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 21 26  1  0
 26 22  2  0
 25 27  2  0
 27 26  1  0
 28 17  1  0
 16 28  1  0
 29 28  1  0
 29 30  2  0
 30 11  1  0
 32 31  2  0
 32 33  2  0
 32 34  1  0
 35 32  1  0
 24 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5209242

    ---

Associated Targets(Human)

XPO1 Tclin Exportin-1 (375 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MM1.S (1111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NAMALVA (207 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
H9 (1832 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
YT (91 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 519.43Molecular Weight (Monoisotopic): 519.0800AlogP: 3.84#Rotatable Bonds: 6
Polar Surface Area: 119.97Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.24CX Basic pKa: 0.72CX LogP: 3.26CX LogD: 3.25
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.38Np Likeness Score: -1.18

References

1. Qu B, Xu Y, Lu Y, Zhuang W, Jin X, Shi Q, Yan S, Guo Y, Shen Z, Che J, Wu Y, Tong L, Dong X, Yang H..  (2022)  Design, synthesis and biological evaluation of sulfonamides inhibitors of XPO1 displaying activity against multiple myeloma cells.,  235  [PMID:35367710] [10.1016/j.ejmech.2022.114257]

Source